Reaction Details
Report a problem with these data
Report a problem with these dataTarget
Pro-glucagon
Ligand
BDBM142041
Substrate
n/a
Meas. Tech.
SPA Assay
pH
7.4±n/a
Ki
25±n/a nM
Citation
Didiuk, M; Filipski, KJ; Guzman-Perez, A; Lee, EC; Pfefferkorn, JA; Stevens, B; Tu, M Quinolinyl glucagon receptor modulators US Patent US8927577 Publication Date 1/6/2015 More Info.:
Target
Name:
Pro-glucagon
Synonyms:
GCG | GLUC_HUMAN | Glucagon | Glucagon receptor (GCGR)
Type:
Enzyme
Mol. Mass.:
20907.95
Organism:
Homo sapiens (Human)
Description:
P01275
Residue:
180
Sequence:
MKSIYFVAGLFVMLVQGSWQRSLQDTEEKSRSFSASQADPLSDPDQMNEDKRHSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNRNNIAKRHDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRGRRDFPEEVAIVEELGRRHADGSFSDEMNTILDNLAARDFINWLIQTKITDRK
Inhibitor
Name:
BDBM142041
Synonyms:
US8927577, 22
Type:
Small organic molecule
Emp. Form.:
C26H28FN3O3
Mol. Mass.:
449.5172
SMILES:
CC1(C)CC(C1)C(Nc1cnc2cc(F)ccc2c1)c1ccc(cc1)C(=O)NCCC(O)=O
Structure:
